BTK modulates p73 activity to induce apoptosis independently of p53

被引:0
作者
Miran Rada
Nickolai Barlev
Salvador Macip
机构
[1] University of Leicester,Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology
[2] Faculty of Science and Education Sciences,Department of Biology, School of Science
[3] University of Sulaimani,Department of Surgery
[4] Sulaimaniyah,undefined
[5] Institute of Cytology,undefined
[6] RAS,undefined
[7] McGill University Health Center Research Institute,undefined
[8] Cancer Research Program,undefined
[9] Moscow Institute of Physics and Technology,undefined
来源
Cell Death Discovery | / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Bruton’s tyrosine kinase (BTK) is a key component of B cell receptor signalling. Because of this, BTK plays an important role in cell proliferation and survival in various B cell malignancies. However, in certain contexts, BTK can also have tumour suppressor functions. We have previously shown that BTK activates the p53 transcriptional activity by binding to and phosphorylating p53, as well as acting on MDM2 to reduce its inhibitory effects. This results in increased p53 functions, including enhanced cell death. Here, we report that BTK can also induce cell death and increase responses to DNA damage independently of p53. This is concomitant to the induction of p21, PUMA and MDM2, which are classic target genes of the p53 family of proteins. Our results show that these p53-independent effects of BTK are mediated through p73. Similar to what we observed in the p53 pathway, BTK can upregulate p73 after DNA damage and induce expression of its target genes, suggesting that BTK is a modulator of p73 functions and in the absence of p53. This effect allows BTK to have pro-apoptotic functions independently of its effects on the p53 pathway and thus play an important role in the DNA damage-related induction of apoptosis in the absence of p53. This provides a novel role of BTK in tumour suppression and contributes to the understanding of its complex pleiotropic functions
引用
收藏
相关论文
共 50 条
[41]   DRAGO, a P53/p73 Regulated Gene That Modulates Survival in Tumour Prone Mouse Model [J].
Rusconi, P. ;
Polato, F. ;
Musi, A. ;
Broggini, M. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 :S223-S223
[42]   p73 in apoptosis [J].
T. Stiewe ;
B. M. Pützer .
Apoptosis, 2001, 6 :447-452
[43]   p53/p63/p73 in the Epidermis in Health and Disease [J].
Botchkarev, Vladimir A. ;
Flores, Elsa R. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2014, 4 (08)
[44]   P63 and p73: P53 mimics, menaces and more [J].
Yang, A ;
McKeon, F .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (03) :199-207
[45]   p63 and p73: p53 mimics, menaces and more [J].
Annie Yang ;
Frank McKeon .
Nature Reviews Molecular Cell Biology, 2000, 1 :199-207
[46]   On the shoulders of giants: p63, p73 and the rise of p53 [J].
Yang, A ;
Kaghad, M ;
Caput, D ;
McKeon, F .
TRENDS IN GENETICS, 2002, 18 (02) :90-95
[47]   P63 and P73 Activation in Cancers with p53 Mutation [J].
Cai, Bi-He ;
Hsu, Yun-Chien ;
Yeh, Fang-Yu ;
Lin, Yu-Rou ;
Lu, Rui-Yu ;
Yu, Si-Jie ;
Shaw, Jei-Fu ;
Wu, Ming-Han ;
Tsai, Yi-Zhen ;
Lin, Ying-Chen ;
Bai, Zhi-Yu ;
Shih, Yu-Chen ;
Hsu, Yi-Chiang ;
Liao, Ruo-Yu ;
Kuo, Wei-Hsin ;
Hsu, Chao-Tien ;
Lien, Ching-Feng ;
Chen, Chia-Chi .
BIOMEDICINES, 2022, 10 (07)
[48]   Alterations of p53 and p73 occur independently of one another in all grades of pediatric diffuse astrocytoma [J].
Ward, S ;
Suarez-Merino, B ;
Ding, Y ;
Hayward, R ;
Harkness, W ;
Thompson, D ;
Phipps, K ;
Thomas, D ;
Warr, T .
NEURO-ONCOLOGY, 2005, 7 (03) :362-362
[49]   p53 and p73 in suppression of Myc-driven lymphomagenesis [J].
Griesmann, Heidi ;
Schlereth, Katharina ;
Krause, Michael ;
Samans, Birgit ;
Stiewe, Thorsten .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (02) :502-506
[50]   p73, a sophisticated p53 family member in the cancer world [J].
Ozaki, T ;
Nakagawara, A .
CANCER SCIENCE, 2005, 96 (11) :729-737